Crohn's & Colitis Foundation meets the 20 Standards for Charity Accountability.
-
Year, State Incorporated
1965, NY
-
Also Known As
Crohn's & Colitis Foundation of America
-
-
Stated Purpose
"to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. Crohn's disease and ulcerative colitis are collectively known as inflammatory bowel diseases (IBD)."
CCF reports that it funds studies at medical institutions, nurtures investigators at the early stages of their careers, and finances underdeveloped areas of research. In addition, the organization offers a range of educational programs for patients and health care professionals, and provides supportive services to help people cope with chronic intestinal diseases.
For the year ended December 31, 2016, Crohn's & Colitis Foundation's program expenses were:
Health professional education and public information |
$31,892,106 |
Research |
$31,577,146 |
Total Program Expenses: |
$63,469,252 |
-
Chief Executive
Michael Osso, President and CEO
-
Compensation*
$421,560
-
Chair of the Board
John Crosson
-
Chair's Profession / Business Affiliation
Marketing and Management Consultant
-
Board Size
26
-
Paid Staff Size
285
*2016 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Invitations to fund raising events, Membership appeals, Planned giving arrangements, Print advertisements (newspapers, magazines, etc.), Radio, Cause- related marketing (affinity credit cards, consumer product sales, etc.), Television
Fundraising costs were 6% of related contributions. (Related contributions, which totaled $74,704,167, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c) (3) of the Internal Revenue Code.It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Crohn's & Colitis Foundation's audited financial statements for the year ended December 31, 2016.
Source of Funds |
Contributions and grants from individuals, foundations and corporations |
$39,318,757 |
Special events revenue, net |
$26,490,694 |
Contributed services and airtime |
$5,599,510 |
Federated campaigns |
$1,636,800 |
Bequests |
$1,197,449 |
Royalties |
$504,368 |
Net realized and unrealized gains on investments |
$464,760 |
Federal grant revenue |
$460,957 |
Other |
$341,375 |
Program service contracts |
$295,805 |
Interest and dividends |
$214,388 |
Total Income |
$76,524,863 |
- Programs: 83%
- Administrative: 11%
- Fundraising: 6%
Total Income |
$76,524,863 |
Program expenses |
$63,469,252 |
Fundraising expenses |
$4,811,942 |
Administrative expenses |
$8,222,517 |
Other expenses |
$0 |
Total expenses: |
$76,503,711 |
Income in Excess of Expenses |
$21,152 |
Beginning Net Assets |
$10,515,576 |
Other Changes In Net Assets |
$-733 |
Ending Net Assets |
$10,535,995 |
Total Liabilities |
$29,800,511 |
Total Assets |
$40,336,506 |
Note 1: According to CCF's 2016 audited financial statements, the organization received in-kind contributions totaling $5,599,510 in the form of airtime ($3,064,209) and professional services ($2,535,301). Note 2: In the financial section above, "other changes in net assets" refers to changes in gift annuities and remainder trust valuations.